Fibrinogenlike protein 1(FGL1) is also known as HP041, Hepassocin, HFREP1, LFIRE1. The protective effect of fibrinogenlike protein 1 (FGL1) in liver injury has previously been reported. However, studies have shown that FGL1 may be a predictor of GC patients and a target for GC therapy. Immunocytochemical studies revealed that fgl1 selectively binds to defective spermatozoa in the cauda epididymidis. Northern blot analysis and in situ hybridization demonstrated the high expression of fgl1 in the principal cells of the proximal cauda epididymidis. Immunofluorescence analysis using mouse fibrotic lung tissues suggested that fibrotic regions showed increased expressions of Gtse1 and Fgl1, Gtse1 and Fgl1 are suggested to be novel targets for radiationinduced lung fibrosis. - Proteine/Peptide
Immobilized Human FGL1, His Tag (Cat. No. FG1-H52Hy) at 1 µg/mL (100 µL/well) can bind Anti-FGL1 MAb with a linear range of 0.004-0.125 µg/mL (QC tested).
Human FGL1, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 90%.
* VAT and and shipping costs not included. Errors and price changes excepted
